Antiviral therapy inhibited HBV-reactivation and improved long-term outcomes in patients who underwent radiofrequency ablation for HBV-related hepatocellular carcinoma

BACKGROUND: Hepatitis B virus (HBV) reactivation impact negatively the prognosis of patients with HBV-related hepatocellular carcinoma (HCC). This study aimed to observe the effect of antiviral therapy (AVT) on viral reactivation and long-term outcomes after percutaneous radiofrequency ablation (PRF...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Jian, Shen, Hao, Huang, Shengyu, Lin, Jianbo, Yan, Zhenlin, Qian, Guojun, Lu, Zhenghua, Wan, Xuying, Zhang, Fabiao, Wang, Kui, Zhang, Yongjie, Li, Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9921597/
https://www.ncbi.nlm.nih.gov/pubmed/36765340
http://dx.doi.org/10.1186/s12957-023-02921-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9921597/
https://www.ncbi.nlm.nih.gov/pubmed/36765340
http://dx.doi.org/10.1186/s12957-023-02921-1

Ejemplares similares